1. Selvas AI H1 2025 Performance: Significant Revenue Decline and Continued Losses

Selvas AI’s H1 2025 revenue decreased by 51.6% year-over-year to ₩54.4 billion, with an operating loss of ₩33.6 billion. The decline is attributed to underperformance in key business segments and increased R&D investment.

2. Core Competencies and Growth Drivers: AI Technology and Healthcare Expansion

Selvas AI boasts 27 years of experience in HCI technology, including voice recognition, synthesis, handwriting recognition, and image intelligence. With a strong patent portfolio, they are expanding into Healthcare and Metaverse applications, focusing on AI-powered healthcare solutions like ‘Selvy Checkup.’ The company aims to leverage synergies with subsidiaries like Selvas Healthcare and Mediana.

3. Investment Outlook: Balancing Opportunities and Risks

While Selvas AI faces short-term challenges, its long-term potential hinges on its AI technology and healthcare expansion strategy. However, increasing competition and the need for improved subsidiary performance remain key concerns.

  • Opportunities: Strong AI technology, business diversification, AI healthcare growth potential
  • Risks: Revenue decline and losses, intensifying competition, subsidiary performance

4. Investor Action Plan: Focus on Profitability and Growth Strategy

Investors should closely monitor Selvas AI’s efforts to improve profitability and the progress of its AI healthcare initiatives. The company’s ability to maintain its technological edge, differentiate its offerings, and navigate the competitive landscape will be crucial for future success.